Randomized pilot study evaluating indisetron tablets for the prevention of acute-onset diarrhea, nausea and vomiting with IRIS or FOLFIRI for metastatic colorectal cancer patients: HGCSG 0704

ABSTRACT: Interventions: indisetrone garnisetrone Primary outcome(s): Incidence of acute-onset diarrhea Complete protection from vomiting Study Design: Parallel Randomized

DISEASE(S): Colorectal Cancer

PROVIDER: 2625553 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR